Suppr超能文献

参与T细胞与同种异体抗原呈递细胞相互作用的限制分子。

Restriction molecules involved in the interaction of T cells with allogeneic antigen-presenting cells.

作者信息

Ishii N, Nagy Z A, Klein J

出版信息

J Exp Med. 1982 Aug 1;156(2):622-7. doi: 10.1084/jem.156.2.622.

Abstract

The proliferative responses of T cells, depleted of alloreactive cells, were tested upon stimulation by antigens presented on allogeneic antigen-presenting cells (APC). Restriction molecules involved in these responses were identified by inhibition of T cell proliferation with monoclonal antibodies against A(A alpha A beta) and E(E alpha E beta) molecules of the APC. The responses to all three antigens tested [Poly(Glu40Ala60) (GA), lactate dehydrogenase B (LDHB), and poly(Glu51, Lys34, Tyr15) (GLT)] were A plus E restricted when the allogeneic APC expressed both molecules, and only A restricted when the APC did not express cell surface E molecules. In contrast, when T cells and APC are syngeneic, the same antigens are recognized only in the context of either A molecules (GA and LDHB) or E molecules (GLT). The data indicate that the immune response gene control of these responses is not associated with either a failure of antigen presentation, or the lack of certain T cell specificities from the germ line repertoire, but probably with selective somatic elimination (tolerance) of certain clones from the T cell repertoire.

摘要

去除同种异体反应性细胞的T细胞在同种异体抗原呈递细胞(APC)呈递的抗原刺激下的增殖反应进行了测试。通过用针对APC的A(AαAβ)和E(EαEβ)分子的单克隆抗体抑制T细胞增殖来鉴定参与这些反应的限制分子。当同种异体APC表达这两种分子时,对所测试的所有三种抗原[聚(Glu40Ala60)(GA)、乳酸脱氢酶B(LDHB)和聚(Glu51,Lys34,Tyr15)(GLT)]的反应受A和E限制,而当APC不表达细胞表面E分子时,反应仅受A限制。相反,当T细胞和APC是同基因时,相同的抗原仅在A分子(GA和LDHB)或E分子(GLT)的背景下被识别。数据表明,这些反应的免疫反应基因控制与抗原呈递失败或种系库中某些T细胞特异性的缺乏无关,而可能与T细胞库中某些克隆的选择性体细胞消除(耐受)有关。

相似文献

引用本文的文献

本文引用的文献

7
Monoclonal antibody against an Ir gene product?针对免疫反应基因产物的单克隆抗体?
J Exp Med. 1980 Oct 1;152(4):1085-101. doi: 10.1084/jem.152.4.1085.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验